Treatment of chronic hepatitis C with interferon alpha: Long-term follow-up and prognostic relevance of HCV genotypes

Journal of Hepatology, Supplement

Volumn 24, Issue 2, 1996, Pages 67-73

  Hopf, Uwe ^a   Berg, Thomas ^a   König, Volker ^a   Küther, Stephan ^a   Heuft, Hans Gerd ^a   Lobeck, Hartmut ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Chronic hepatitis C; HCV genotypes; Interferon alpha therapy

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHAN1 INTERFERON; RECOMBINANT ALPHA2A INTERFERON; VIRUS RNA;

ADULT; AGED; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; FEMALE; FOLLOW UP; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; REMISSION; RETROSPECTIVE STUDY; RNA ANALYSIS;

ADULT; AGED; ALANINE TRANSAMINASE; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON TYPE I, RECOMBINANT; LIVER; MALE; MIDDLE AGED; PROGNOSIS; RNA, VIRAL;

EID: 0029815925     PISSN: 01695185     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (45)

1. Davis GL, Baiart LA, Schiff ER, Lindsay K, Bodenheimer HC Jr, Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL, et al. Treatment of chronic hepatitis C with recombinant interferon alpha. A multicenter randomized, controlled trial. Hepatitis Interventional Therapy Group. N Engl J Med 1989; 321: 1501-6.
2. Di Bisceglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J, Goodman Z, Banks SM, Hoofnagle JH. Recombinant interferon alpha therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. N Engl J Med 1989; 321: 1506-10.
3. Hopf U. Möller B, König V, Küther S, Lobeck H, Huhn D. Long-term treatment of cryptogenic hepatitis C using recombinant interferon alpha. Z Gastroenterol 1990; 28: 453-7.
4. Schwarcz R, Glaumann H, Weiland O, Norkrans G, Wejstal R, Fryden A. Interferon alpha-2b treatment of chronic posttransfusion non-A, non-B/C hepatitis: long-term outcome and effect of increased interferon doses in non-responders. Scand J Infect Dis 1991; 23: 413-20.
5. Shindo M, Di Bisceglie AM, Cheung L, Shih JW, Cristiano K, Feinstone SM, Hoofnagle JH. Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C. Ann Intern Med 1991; 115: 700-4.
6. Marcellin P, Boyer N, Giostra E, Degott C, Courouce AM, Degos F, Coppere H, Cales P, Couzigou P, Benhamou JP. Recombinant human alpha-interferon in patients with chronic non-A, non-B hepatitis: a multicenter randomized controlled trial from France. Hepatology 1991; 13: 393-7.
7. Causse X, Godinot H, Chevallier M, Chossegros P, Zoulim F, Ouzan D, Heyraud JP, Fontanges T, Albrecht J, Meschievitz C, et al. Comparison of 1 or 3 MU of interferon alpha-2b and placebo in patients with chronic non-A, non-B hepatitis. Gastroenterology 1991; 101: 497-502.
8. Boyer N, Marcellin P, Degott C, Degos F, Saimot AG, Erlinger S, Benhamou JP. Recombinant interferon-alpha for chronic hepatitis C in patients positive for antibody to human immunodeficiency virus. Comité des Anti-Viraux. J Infect Dis 1992; 165: 723-6.
9. Chayama K, Saitoh S, Arase Y, Ikeda K, Matsumoto T, Sakai Y, Kobiyashi M, Unakami M, Morinaga T, Kumada H. Effect of interferon administration on serum hepatitis C virus RNA in patients with chronic hepatitis C. Hepatology 1991; 13: 1040-3.
10. Shindo M, Di Bisceglie AM, Hoofnagle JH. Long-term follow-up of patients with chronic hepatitis C treated with alpha-interferon. Hepatology 1992; 15: 1013-6.
11. Hagiwara H, Hayashi N, Mita E, Ueda K, Takehara T, Kasahara A, Fusamoto H, Kamada T. Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-alpha. Hepatology 1992: 15: 37-41.
12. De Bac C, Grimaldi F, dementi C, Duca F, Livoli D, Taliani G. Efficacy of different regimens of interferon alpha-2b treatment in chronic hepatitis C. Gut 1993; 34: S135.
13. Baiart LA, Perrillo R, Roddenberry J, Regenstein F, Shim KS, Shieh YS, Taylor B, Dash S, Gerber MA. Hepatitis C RNA in liver of chronic hepatitis C patients before and after interferon alpha treatment. Gastroenterology 1993; 104: 1472-7.
14. Mondazzi L, Bottelli R, Zavaglia C, Bellati G, Bellobuono A, Ideo G. Chronic hepatitis C: long-term follow-up of sustained responders to alpha-IFN treatment. Hepatology 1993; 18:91A.
15. Saracco G, Rosina F, Abate ML, et al. Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon alpha-26. Hepatology 1993; 18: 1300-5.
16. Hopf U, Küther S, König V. Langzeitbeobachtung der chronischen Hepatitis C nach Behandlung mit rekombinantem Interferon alpha-2a. Gastroenterology 1994; 32: 425-30.
17. Castilla A, Camps-Bansell J, Civeira MP, Prieto J. Lymphoblastoid alpha-interferon for chronic hepatitis C: a randomized controlled study. Am J Gastroenterol 1993; 88: 2339.
18. Yamada G, Takahashi M, Endo H, Doi T, Miyamoto R, Shimomura H, Yamamoto K, Tsuji T. Quantitative hepatitis C virus RNA and liver histology in chronic hepatitis C patients treated with interferon alpha. Gut 1993; 34: 51334.
19. Hopf U, Möller B, Küther D, Stemerowicz R, Lobeck H, Lüdtke-Handjery A, Walter E, Blum HE, Roggendorf M, Deinhardt F. Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV). J Hepatol 1990; 10: 69-76.
20. Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, Beall E, Yap PL, Kolberg J, Urdea MS. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993; 74: 2391-9.
21. Dusheiko G, Schmilovitz-Weiss H, Brown D, McOmish F, Yap PL, Sherlock S, Mcintyre N, Simmonds P. Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology 1994; 19: 13-8.
22. McOmish F, Yap PL, Dow BC, Follett EAC, Seed C, Keller AJ, Cobain TJ, Krusius T, Kolho E, Naukkarinen R, Lin C, Lai C, Leong S, Medgyesi GA, Hejjas, Kiyokawa H, Fukada K, Cuypers T, Saeed AA, Al-Rasheed AM, Lin M, Simmonds P. Geographical distribution of hepatitis C virus geno-types in blood donors: an international collaborative survey, J Clin Microbiol 1994; 32: 884-92.
23. Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M, Higashi Y, Shibata M, Morishima T. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus. Hepatology 1992; 16: 293-9.
24. Kanal K, Kako M, Okamoto H. HCV genotypes in chronic hepatitis C and response to interferon. Lancet 1992; 339: 1543.
25. Chemello 1, Albert! A, Rose K, Simmonds P. Hepatitis C serotype and response to interferon therapy. N Engl J Med 1994; 330: 143.
26. Dusheiko G, Albert! A, Columbo M, Craxi A, Frost C, Prieto J, Sanchez Tapias J, Simmonds P. The influence of serotypes of hepatitis C virus on sustained response to alpha interferon treatment. J Hepatol 1994; 21 (Suppl.l): S17.
27. Hino K, Sainokami S, Shimoda K, lino S, Wang Y, Okamoto H, Myakawa Y, Mayumi M. Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C. J Med Virol 1994; 42: 299-305.
28. Okada S-I, Akahane Y, Suzuki H, Okamoto H, Mishiro S. The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with the responsiveness to interferon therapy in viremic patients. Hepatology 1992; 16: 619-24.
29. Viazov S, Zibert A, Widell A, Cavicchini A, Schreier E, Roggendorf M. Typing of hepatitis C virus isolates by DNA enzyme immunoassay. J Virol Methods 1994; 48: 81-92.
30. Driesel G, Wirth D, Stark K, Baumgarten R, Sucker U, Schreier E. Hepatitis C virus (HCV) genotype distribution in German isolates: studies on the sequence variability in the E2 and NS5 region. Arch. Virol 1995: in press.
31. Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, Beall E, Yap PL, Kolberg J, Urdea MS. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993; 74: 2391-9.
32. Simmonds P, Albert! A, Alter HJ, Bonino F, Bradley DW, Brechet C, Brouwer JT, et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994; 19: 1321.
33. Mondelli MU, Cerino A, Bono F, Cividini A, Maccabruni A, Arico M, Malfitano A, Barbarini G, Piazza V, Minoli L, Silini E. Hepatitis C virus (HCV) core serotypes in chronic HCV infection. J Clin Microbiol 1994; 32: 2523-7.
34. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; I: 431-5.
35. Rumi MG, Parravicini ML, Donato MF, Soffredini R, Wilber JC, Chan CS, Newald P, Urdea M, Del Ninno E, Colombo M. Pretreatment quantitative serum HCV-RNA and longterm response to alpha interferon (IFN) in chronic hepatitis C. Hepatology 1993; 18: 89A.
36. Kaneko S, Murakami S, Unoura M, Kobayashi K. Quantitation of hepatitis C virus RNA by competitive polymerase chain reaction. J Med Virol 1992; 37: 278-82.
37. Kato N, Yokosuka O, Hosoda K, Ito Y, Ohio M, Omata M. Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease. Hepatology 1993; 18: 16-20.
38. Hagiwara H, Hayashi N, Mita E, Takehara T, Kasahara A, Fusamoto H, Kamada T. Quantitative analysis of hepatitis C virus RNA in serum during interferon alpha therapy. Gastroenterology 1993; 104: 877-83.
39. Lau JY, Davis GL, Kniffen J, Qian KP, Urdea MS, Chan CS, Mizokami M, Neuwald PD, Wilber JC. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993; 341: 1501-4.
40. Martinot-Peignoux M, Marcellin P, Gournay J, Gabriel F, Courtois F, Branger M, Wild AM, Erlinger S, Benhamou JP. Detection and quantitation of serum HCV-RNA by branched DNA amplification in anti-HCV positive blood donors. J Hepatol 1994; 20: 676-8.
41. Blatt LM, Conrad A, Schmid P, Co R, Tong MJ. A retrospective study of HCV-RNA status in patients with chronic HCV infection by quantitative polymerase chain reaction analysis. Hepatology 1993; 18: 82A.
42. Gretch D, Han J, Willson R, Carithers R Jr, Busch M, Sayers M, Corey L. High titer hepatitis C virus infection is associated with advanced disease stage and resistance to interferon. Hepatology 1993; 18: 88A.
43. Berg T, König V, Küther S, Heuft HG, Hopf U. Prognostische Relevanz der Hepatitis-C-Virus-Genotypen für das Ansprechen auf Interferon alpha. Z Gastroenterol 1995; 33: 426-30.
44. Pistello M, Maggi F, Vatteroni L, Cecconi N, Panicucci F, Bresci GP, Gambardella L, Taddei M, Bionda A, Tuoni M, Bendinelli M. Prevalence of hepatitis C virus genotypes in Italy. J Clin Microbiol 1994; 32: 232-4.
45. Kinoshita T, Miyake K, Okamoto H, Mishiro S. Imported hepatitis C virus genotypes in Japanese hemophiliacs. J Infect Dis 1993; 168: 249-50.